Clinical Trial Update: Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metronomic capecitabine with camrelizumab and apatinib mesylate for advanced pancreatic cancer; the study status is NOT_YET_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Capecitabine (capecitabine)

Snippet

Sponsor: Zhejiang University | Conditions: Metastatic Pancreatic Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING